Articulo
Genomic Analysis On Subjects Exposed To Arsenic Identifies Genetic Risk Variants Associated With Bladder Cancer And Variants Under Recent Adaptive Selection
Journal Of Urology
Registro en:
1120987
1120987
Autor
Fernández-Arancibia, Mario Ignacio
Vicuña, Lucas
Valdebenito, Patricio
Chaparro, Eduardo
Vial, Cecilia
Ziegler, Annemarie
Bustamante, Alberto
Eyheramendy, Susana
Institución
Resumen
INTRODUCTION AND OBJECTIVES: Only a small fraction of arsenic-exposed subjects is affected by malignant iseases. This suggests the existence of genetic risk factors influencing susceptibility to arseniasis and its consequences, such as bladder  cancer  (BC).  Here,  we  evaluate  this  hypothesis  by  performing  a  case-control  genome-wide  association  study (GWAS) for BC in subjects exposed to significantly elevated drinking-water arsenic levels in Northern Chile. Furthermore, since native people of this region have been exposed  for  thousands  of  years  to  arsenic  present  in  underground water due to volcanic activity, they and their  descendants might have adapted to this selective pressure.  Therefore, we tested for adaptive selection since we also  hypothesized that control subjects from this cohort might have inherited protective genetic variants. METHODS:  Demographic and clinical data were collected using a structured questionnaire and a blood sample was  obtained. DNA samples were analyzed using Affymetrix Genome-Wide SNP Array 6.0. After filtering by missingness  per individual and per marker allele frequency and Hardy  Weinberg  Equilibrium  we  obtained  788,705  SNPs  to  be  analyzed. Estimates of adaptive (Darwinian) selection by  comparing allele frequencies that are unusually high in one vs. two related populations were performed using the  Population Branch Statistics (PBS) test.  Several  associations  reaching  genome-wide   significance  were  identified  after  adjusting  for  global  ancestry, age, sex, smoking habit and occupational risk  factors. Whereas some of these variants mapped in genes without  a  previous  relation  to  BC  and  thus  constitute  novel  candidates  for  BC  carcinogenesis,  others  were   located in genes related to BC. For instance, an intron  variant associated with CTNNA2, a gene linked to BC after  undergoing epigenetic modifications in response to arsenic exposure. We further found a variant close to CHL1, which  has been associated with arsenic toxicity in cell lines and also  to occurrence of BC by acting as a tumor suppressor. PBS  test found several candidate variants for adaptive selection  in the control group when compared to populations from  Asia (CHB/JPT) and Central/ North America (Maya/Nahua).  Several of these variants have also been associated with BC  and  arsenic-related  processes,  including  two  intron   variants in CTNNA2. CONCLUSIONS: The results of this study contribute to a  better understanding of the genetic factors affecting BC in subjects exposed to arsenic and shed light into the recent  evolutionary history of Native Americans. Candidate risk  SNPs identified need to be further validated in independent  analyses. Source of Funding: Fondecyt Regular 1120987, Conicyt, Chile